Clinical Focus ›› 2026, Vol. 41 ›› Issue (1): 78-83.doi: 10.3969/j.issn.1004-583X.2026.01.014
• Original article • Previous Articles Next Articles
-
Received:2025-11-25Online:2026-01-20Published:2026-02-02
CLC Number:
Cite this article
share this article
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.lchc.cn/EN/10.3969/j.issn.1004-583X.2026.01.014
| [1] | Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: International guidelines for management of sepsis and septic shock 2021[J]. Intensive Care Med, 2021, 47(11):1181-1247. doi: 10.1007/s00134-021-06506-y. |
| [2] | Zarbock A, Nadim MK, Pickkers P, et al. Sepsis-associated acute kidney injury: Consensus report of the 28th Acute Disease Quality Initiative workgroup[J]. Nat Rev Nephrol, 2023, 19(6):401-417. doi: 10.1038/s41581-023-00683-3. |
| [3] | Liu J, Xie H, Ye Z, et al. Rates, predictors, and mortality of sepsis-associated acute kidney injury: A systematic review and meta-analysis[J]. BMC Nephrol, 2020, 21(1):318. doi: 10.1186/s12882-020-01974-8. |
| [4] | Kellum JA, Chawla LS, Keener C, et al. The effects of alternative resuscitation strategies on acute kidney injury in patients with septic shock[J]. Am J Respir Crit Care Med, 2016, 193(3):281-287. doi: 10.1164/rccm.201505-0995OC. |
| [5] | Bouchard J, Acharya A, Cerda J, et al. A prospective international multicenter study of AKI in the intensive care unit[J]. Clin J Am Soc Nephrol, 2015, 10(8):1324-1331. doi: 10.2215/CJN.04360514. |
| [6] | Mehta RL, Bouchard J, Soroko SB, et al. Sepsis as a cause and consequence of acute kidney injury: Program to improve care in acute renal disease[J]. Intensive Care Med, 2011, 37(2):241-248. doi: 10.1007/s00134-010-2089-9. |
| [7] | Kellum JA, Sileanu FE, Murugan R, et al. Classifying AKI by urine output versus serum creatinine level[J]. J Am Soc Nephrol, 2015, 26(9):2231-2238. doi: 10.1681/ASN.2014070724. |
| [8] | Sood MM, Shafer LA, Ho J, et al. Early reversible acute kidney injury is associated with improved survival in septic shock[J]. J Crit Care, 2014, 29(5):711-717. doi: 10.1016/j.jcrc.2014.04.003. |
| [9] | Peerapornratana S, Manrique-Caballero CL, Gómez H, et al. Acute kidney injury from sepsis: Current concepts, epidemiology, pathophysiology, prevention and treatment[J]. Kidney Int, 2019, 96(5):1083-1099. doi: 10.1016/j.kint.2019.05.026. |
| [10] | Murugan R, Karajala-Subramanyam V, Lee M, et al. Acute kidney injury in non-severe pneumonia is associated with an increased immune response and lower survival[J]. Kidney Int, 2010, 77(6):527-535. doi: 10.1038/ki.2009.502. |
| [11] | Langenberg C, Wan L, Egi M, et al. Renal blood flow in experimental septic acute renal failure[J]. Kidney Int, 2006, 69(11):1996-2002. doi: 10.1038/sj.ki.5000440. |
| [12] | Gomez H, Ince C, De Backer D, et al. A unified theory of sepsis-induced acute kidney injury: Inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury[J]. Shock, 2014, 41(1):3-11. doi: 10.1097/SHK.0000000000000052. |
| [13] | Dellepiane S, Marengo M, Cantaluppi V. Detrimental cross-talk between sepsis and acute kidney injury: New pathogenic mechanisms, early biomarkers and targeted therapies[J]. Crit Care, 2016, 20(1):61. doi: 10.1186/s13054-016-1219-3. |
| [14] | Prowle JR, Bellomo R. Sepsis-associated acute kidney injury: Macrohemodynamic and microhemodynamic alterations in the renal circulation[J]. Semin Nephrol, 2015, 35(1):64-74. doi: 10.1016/j.semnephrol.2015.01.007. |
| [15] | Verma SK, Molitoris BA. Renal endothelial injury and microvascular dysfunction in acute kidney injury[J]. Semin Nephrol, 2015, 35(1):96-107. doi: 10.1016/j.semnephrol.2015.01.010. |
| [16] | Darmon M, Timsit JF, Francais A, et al. Association between hypernatraemia acquired in the ICU and mortality: A cohort study[J]. Nephrol Dial Transplant, 2010, 25(8):2510-2515. doi: 10.1093/ndt/gfq067. |
| [17] | Li Z, Lu S, Li X. The role of metabolic reprogramming in tubular epithelial cells during the progression of acute kidney injury[J]. Cell Mol Life Sci, 2021, 78(15):5731-5741. doi: 10.1007/s00018-021-03892-w. |
| [18] | Gómez H, Kellum JA, Ronco C. Metabolic reprogramming and tolerance during sepsis-induced AKI[J]. Nat Rev Nephrol, 2017, 13(3):143-51. doi: 10.1038/nrneph.2016.186. |
| [19] | Zhu Z, Hu J, Chen Z, et al. Transition of acute kidney injury to chronic kidney disease: Role of metabolic reprogramming[J]. Metabolism, 2022, 131:155194. doi: 10.1016/j.metabol.2022.155194. |
| [20] | van Mourik N, Geerts BF, Binnekade JM, et al. A higher fluid balance in the days after septic shock reversal is associated with increased mortality: An observational cohort study[J]. Crit Care Explor, 2020, 2(10):e0219. doi: 10.1097/CCE.0000000000000219. |
| [21] | Chua HR, Wong WK, Ong VH, et al. Extended mortality and chronic kidney disease after septic acute kidney injury[J]. J Intensive Care Med, 2020, 35(6):527-535. doi: 10.1177/0885066618764617. |
| [22] | Macdonald SPJ, Keijzers G, Taylor DM, et al. Restricted fluid resuscitation in suspected sepsis associated hypotension (REFRESH): A pilot randomised controlled trial[J]. Intensive Care Med, 2018, 44(12):2070-2078. doi: 10.1007/s00134-018-5433-0. |
| [23] | Shahnoor H, Divi R, Palle LRA, et al. The effects of restrictive fluid resuscitation on the clinical outcomes in patients with sepsis or septic shock: A meta-analysis of randomized- controlled trials[J]. Cureus, 2023, 15(9):e45620. doi: 10.7759/cureus.45620. |
| [24] | Kellum JA, Mythen MG, Shaw AD. The 12th consensus conference of the acute dialysis quality initiative (ADQI XII)[J]. Br J Anaesth, 2014, 113(5):729-731. doi: 10.1093/bja/aeu140. |
| [25] | Kellum DJA, Chawla DLS, Keener MC, et al. The effects of alternative resuscitation strategies on acute kidney injury in patients with septic shock[J]. Am J Respir Crit Care Med, 2016, 193(3):281-287. doi: 10.1164/rccm.201505-0995OC. |
| [26] | Semler MW, Self WH, Wanderer JP, et al. Balanced crystalloids versus saline in critically Ill adults[J]. N Engl J Med, 2018, 378(9):829-839. doi: 10.1056/NEJMoa1711584. |
| [27] | Zampieri FG, Cavalcanti AB, Di Tanna GL, et al. Balanced crystalloids versus saline for critically ill patients (BEST-Living): A systematic review and individual patient data meta-analysis[J]. Lancet Respir Med, 2024, 12(3):237-246. doi: 10.1016/S2213-2600(23)00417-4. |
| [28] | Caironi P, Tognoni G, Masson S, et al. Albumin replacement in patients with severe sepsis or septic shock[J]. N Engl J Med, 2014, 370(15):1412-1421. doi: 10.1056/NEJMoa1305727. |
| [29] | Frenette AJ, Bouchard J, Bernier P, et al. Albumin administration is associated with acute kidney injury in cardiac surgery: A propensity score analysis[J]. Crit Care, 2014, 18(6):602. doi: 10.1186/s13054-014-0602-1. |
| [30] | Skytte Larsson J, Bragadottir G, Redfors B, et al. Renal effects of norepinephrine-induced variations in mean arterial pressure after liver transplantation: A randomized cross-over trial[J]. Acta Anaesthesiol Scand, 2018, 62(9):1229-36. doi: 10.1111/aas.13156. |
| [31] | Lankadeva YR, Kosaka J, Evans RG, et al. Intrarenal and urinary oxygenation during norepinephrine resuscitation in ovine septic acute kidney injury[J]. Kidney Int, 2016, 90(1):100-108. doi: 10.1016/j.kint.2016.02.017. |
| [32] | Al-Husinat L, Alsabbah A, Hmaid AA, et al. Norepinephrine may exacerbate septic acute kidney injury: A narrative review[J]. JCM, 2023, 12(4):1373. doi: 10.3390/jcm12041373. |
| [33] | Gordon AC, Mason AJ, Thirunavukkarasu N, et al. Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: The VANISH randomized clinical trial[J]. JAMA, 2016, 316(5):509. doi: 10.1001/jama.2016.10485. |
| [34] | Gordon AC, Russell JA, Walley KR, et al. The effects of vasopressin on acute kidney injury in septic shock[J]. Intensive Care Med, 2010, 36(1):83-91. doi: 10.1007/s00134-009-1687-x. |
| [35] | Kalantari K, Rosner MH. Recent advances in the pharmacological management of sepsis-associated acute kidney injury[J]. Expert Rev Clin Pharmacol, 2021, 14(11):1401-1411. doi: 10.1080/17512433.2021.1978287. |
| [36] | Lankadeva YR, Kosaka J, Evans RG, et al. Urinary oxygenation as a surrogate measure of medullary oxygenation during angiotensin ii therapy in septic acute kidney injury[J]. Crit Care Med, 2018, 46(1):e41-e48. doi: 10.1097/CCM.0000000000002797. |
| [37] | Wan L, Langenberg C, Bellomo R, et al. Angiotensin II in experimental hyperdynamic sepsis[J]. Crit Care, 2009, 13(6):R190. doi: 10.1186/cc8185. |
| [38] | Tumlin JA, Murugan R, Deane AM, et al. Outcomes in patients with vasodilatory shock and renal replacement therapy treated with intravenous angiotensin II[J]. Crit Care Med, 2018, 46(6):949-957. doi: 10.1097/CCM.0000000000003092. |
| [39] | Asfar P, Meziani F, Hamel JF, et al. High versus low blood-pressure target in patients with septic shock[J]. N Engl J Med, 2014, 370(17):1583-1593. doi: 10.1056/NEJMoa1312173. |
| [40] | Lamontagne F, Richards-Belle A, Thomas K, et al. Effect of reduced exposure to vasopressors on 90-day mortality in older critically ill patients with vasodilatory hypotension: A randomized clinical trial[J]. JAMA, 2020, 323(10):938. doi: 10.1001/jama.2020.0930. |
| [41] | Zarbock A, Kellum JA, Schmidt C, et al. Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: The ELAIN randomized clinical trial[J]. JAMA, 2016, 315(20):2190. doi: 10.1001/jama.2016.5828. |
| [42] | Fan Y, Chen L, Jiang S, et al. Timely renal replacement therapy linked to better outcome in patients with sepsis-associated acute kidney injury[J]. J Intensive Med, 2022, 2(3):173-182. doi: 10.1016/j.jointm.2022.03.004. |
| [43] | Pickkers P, Heemskerk S, Schouten J, et al. Alkaline phosphatase for treatment of sepsis-induced acute kidney injury: A prospective randomized double-blind placebo-controlled trial[J]. Crit Care, 2012, 16(1):R14. doi: 10.1186/cc11159. |
| [44] | Pickkers P, Mehta RL, Murray PT, et al. Effect of human recombinant alkaline phosphatase on 7-day creatinine clearance in patients with sepsis-associated acute kidney injury: A randomized clinical trial[J]. JAMA, 2018, 320(19):1998. doi: 10.1001/jama.2018.14283. |
| [45] | Pickkers P, Angus DC, Arend J, et al. Study protocol of a randomised, double-blind, placebo-controlled, two-arm parallel-group, multi-centre phase 3 pivotal trial to investigate the efficacy and safety of recombinant human alkaline phosphatase for treatment of patients with sepsis-associated acute kidney injury[J]. BMJ Open, 2023, 13(4):e065613. doi: 10.1136/bmjopen-2022-065613. |
| [46] | Lerolle N, Nochy D, Guérot E, et al. Histopathology of septic shock induced acute kidney injury: Apoptosis and leukocytic infiltration[J]. Intensive Care Med, 2010, 36(3):471-478. doi: 10.1007/s00134-009-1723-x. |
| [47] | Guo R, Wang Y, Minto AW, et al. Acute renal failure in endotoxemia is dependent on caspase activation[J]. J Am Soc Nephrol, 2004, 15(12):3093-3102. doi: 10.1097/01.ASN.0000145530.73247.F5. |
| [48] | Eirin A, Li Z, Zhang X, et al. A mitochondrial permeability transition pore inhibitor improves renal outcomes after revascularization in experimental atherosclerotic renal artery stenosis[J]. Hypertension, 2012, 60(5):1242-1249. doi: 10.1161/HYPERTENSIONAHA.112.199919. |
| [49] | De Barcelos IP, Emmanuele V, Hirano M. Advances in primary mitochondrial myopathies[J]. Curr Opin Neurol, 2019, 32(5):715-721. doi: 10.1097/WCO.0000000000000743. |
| [1] | Shen Jian, Yu Sheng, Gu Xiaolei, Xia Tian, Gong Ju. Application of multiplex RT-qPCR in pathogen detection for septic patients [J]. Clinical Focus, 2025, 40(9): 796-800. |
| [2] | . [J]. Clinical Focus, 2025, 40(1): 82-85. |
| [3] | . [J]. Clinical Focus, 2024, 39(1): 70-74. |
| [4] | Tang Aijun, Wang Liwei. Predictive values of platelet count and coagulation index in the 28-day survival of sepsis patients [J]. Clinical Focus, 2023, 38(3): 250-254. |
| [5] | Zhou Bin, Zeng Cizheng, Huang Yuge, Zhong Mianling, Wu Jiayuan. Effect of pSOFA score combined with C-reactive protein and procalcitonin in prognosis assessment of sepsis children [J]. Clinical Focus, 2022, 37(7): 616-622. |
| [6] | Zhang Mengyuan, Zhu Yong. Predictive value of procalcitonin clearance and SOFA score on the prognosis of patients with severe sepsis [J]. Clinical Focus, 2022, 37(3): 225-229. |
| [7] | Xiao Liuniu, Zhong Yanxia, Li Shusheng. Effect of extracorporeal hemopurification for clinical prognosis and cytokine levels of septic: A meta-analysis [J]. Clinical Focus, 2022, 37(1): 5-13. |
| [8] | . [J]. Clinical Focus, 2021, 36(10): 946-950. |
| [9] | Hou Wei, Zhang Lijun, Zhang Man, Wang Yakun, Jia Meixuan, Tian Liyuan. Clinical analysis in 84 children with the sepsis of non-elevated peripheral blood leukocytes [J]. Clinical Focus, 2021, 36(9): 799-802. |
| [10] | Jia Yajie, Yao Ming. Effect of limited and open fluid resuscitation on respiratory mechanics and oxygen metabolism in septic shock patients [J]. Clinical Focus, 2021, 36(9): 803-806. |
| [11] | Dong Hong, Zhang Huizhi,Qian Qinjuan. Change of Tregs cells percentage, interferon-γ, interleukin-4 and CD25 level in sepsis patients of intensive care unit [J]. Clinical Focus, 2016, 31(1): 63-67. |
| [12] | Lu Chengxiang;Sun Dejun;Qiu Ting. Role of lactate clearance in evaluation of therapeutic efficacy and prognosis of severe sepsis and septic shock caused by infectious wounds [J]. Clinical Focus, 2015, 30(10): 1152-1155. |
| [13] | . [J]. Clinical Focus, 2015, 30(4): 468-471. |
| [14] | PENG Huan-qing;PENG Zhi-yun;FAN Zhi-yong;TANG Zhong-xiang;LIN Hui-wen;LI Feng-hui;WANG Ying-jing. Influence of ulinastatin on von Willebrand factor and thrombomodulin in patients with sepsis [J]. Clinical Focus, 2014, 29(9): 1012-1.0141e+007. |
| [15] | WANG Xia;TONG Fei;CHEN Hui;HUO Shu-hua;LIU Fang;LIU Zhi-kuan;ZHANG Man-li;ZHAO Kun;LIU Fu-rong. Clinical effect of ω-3 polyunsaturated fatty acid on patients with abdominal sepsis [J]. Clinical Focus, 2014, 29(5): 502-504508. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||